3 completed, 2 active not recruiting, 1 enrolling by invitation, 1 recruiting. 3 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Enrolling by invitation 1 |
| Not applicable | 1 | Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Tolmar Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months Jatenzo Oral Product - Hypogonadism | Phase 4 | Completed | Tolmar Inc. | 116 | 2024-07-02 | 2026-10-02 |
| Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study TOL2506, Tamoxifen, Letrozole tablets - Breast Cancer | Phase 3 | Enrolling by invitation | Tolmar Inc. | 250 | 2022-12-28 | 2026-10-23 |
| Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer TOL2506, Tamoxifen, Letrozole Tablets - Breast Cancer | Phase 3 | Active not recruiting | Tolmar Inc. | 250 | 2021-07-01 | 2026-10-23 |
| Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer Eligard - Prostate Cancer | Phase 2 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 77 | 2019-09-03 | 2025-06-25 |
| BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis Calcipotriene and betamethasone suspension, Taclonex, Placebo - Scalp Psoriasis | Phase 1 | Completed | Tolmar Inc. | 699 | 2017-04-11 | 2018-03-07 |
| A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients Nutrition, Exercise, Smoking cessation - Prostate Cancer, Cardiovascular Disease | Not applicable | Active not recruiting | McMaster University | 5000 | 2015-10-21 | 2026-07-02 |
| Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty Leuprolide Acetate 45 mg - Precocious Puberty, Central | Phase 3 | Completed | Tolmar Inc. | 64 | 2015-08-31 | 2020-06-02 |
Breast Neoplasms (2) · Neoplasms (2) · Prostatic Neoplasms (2) · Cardiovascular Diseases (1) · Hypogonadism (1) · Puberty, Precocious (1)
Anastrozole (2) · Letrozole (2) · Tamoxifen (2) · exemestane (2) · Angiotensin-Converting Enzyme Inhibitors (1) · Atorvastatin (1) · Betamethasone (1) · Exercise (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Leuprolide (1) · Nutritional Status (1) · Pravastatin (1) · Radiation (1) · Rosuvastatin Calcium (1) · Simvastatin (1)
United States (6) · Canada (4) · Argentina (3) · Brazil (3) · India (3) · Mexico (3) · Puerto Rico (2) · Australia (1) · Chile (1) · Colombia (1) · Israel (1) · New Zealand (1) · Singapore (1) · Turkey (Türkiye) (1)
Dr. Darryl Leong, MBBs,MPH,PhD,FRACP,FESC (1) · E P Hamilton (1) · Fabio Cury, MD (1) · Jim Joffrion (1) · Peggy Schorr (1)